| |
| |
|
| Insider
Information: |
Schoemaker Kathleen K |
| Relationship: |
10% Owner |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
24 |
|
| Direct
Shares |
8,715,548 |
|
|
Indirect Shares
|
3,038,103 |
|
|
| Direct
Value |
$228,247,061 |
|
|
|
Indirect Value
|
$11,224,701 |
|
|
| Total
Shares |
11,753,651 |
|
|
| Total
Value |
$239,471,762 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-10 |
37,586 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2009-01-30 |
67,875 |
Premium* |
|
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
29,887 |
2008-07-16 |
62,513 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
2014-02-12 |
2,972,678 |
2014-03-19 |
0 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
9,058 |
2011-12-22 |
50,643 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2014-01-16 |
3,590,931 |
2011-06-02 |
40,790 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2013-06-04 |
44,034 |
2011-11-21 |
51,013 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
|
Glaukos Corp |
GKOS |
10% Owner |
2015-06-30 |
2,068,960 |
2015-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2014-03-19 |
4 |
D |
$14.00 |
$146,195,434 |
I/I |
(10,442,531) |
0 |
0 |
- |
|
| VOLC |
Volcano Corp |
10% Owner |
– – • |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
I/I |
9,750,411 |
132,732 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2006-10-30 |
4 |
A |
$0.00 |
$0 |
I/I |
5,713,622 |
60,584 |
0 |
- |
|
| ALIM |
Alimera Sciences Inc |
10% Owner |
– – • |
2010-04-27 |
4 |
A |
$0.00 |
$0 |
I/I |
4,499,449 |
47,704 |
0 |
- |
|
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2010-11-29 |
4 |
A |
$0.00 |
$0 |
I/I |
4,252,587 |
106 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2007-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
3,763,807 |
92,859 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
A |
$0.00 |
$0 |
I/I |
3,731,218 |
87,424 |
|
- |
|
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2011-09-16 |
4 |
B |
$2.00 |
$7,000,000 |
I/I |
3,500,000 |
169,251 |
1.5 |
- |
|
| TNDM |
Tandem Diabetes Care Inc |
10% Owner |
– – • |
2013-11-19 |
4 |
A |
$0.00 |
$0 |
I/I |
3,243,448 |
54,390 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2006-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
3,203,594 |
33,968 |
|
- |
|
| VCYT |
Veracyte, Inc. |
10% Owner |
– – • |
2013-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
3,086,024 |
22,730 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
– – • |
2005-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,889,086 |
32,297 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2008-02-20 |
4 |
A |
$5.34 |
$14,999,996 |
I/I |
2,808,988 |
90,369 |
0 |
- |
|
| SNTS |
Santarus Inc |
10% Owner |
– – • |
2004-04-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,793,668 |
64,471 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2009-02-18 |
4 |
B |
$7.13 |
$19,826,206 |
I/I |
2,780,674 |
46,634 |
1.5 |
- |
|
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2010-11-29 |
4 |
B |
$4.00 |
$9,399,996 |
I/I |
2,349,999 |
110,555 |
1.5 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
10% Owner |
– – • |
2012-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
2,244,125 |
16,529 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
10% Owner |
– – • |
2011-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,110,267 |
35,388 |
0 |
- |
|
| NSTR |
Northstar Neuroscience In... |
10% Owner |
– – • |
2006-05-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,106,086 |
37,586 |
|
- |
|
| GKOS |
Glaukos Corp |
10% Owner |
– – • |
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,057,190 |
2,057,190 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2014-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
2,020,939 |
33,890 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
10% Owner |
– – • |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,816,474 |
30,462 |
0 |
- |
|
| TBRA |
Tobira Therapeutics Inc |
10% Owner |
– – • |
2013-08-27 |
4 |
A |
$0.00 |
$0 |
I/I |
1,800,109 |
14,920 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
10% Owner |
– – • |
2014-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,765,711 |
13,004 |
0 |
- |
|
| NUVA |
Nuvasive Inc |
10% Owner |
– – • |
2004-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,657,444 |
31,204 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
